IGI, Laboratories, Inc. (IG) in Focus: Stock up 11.7%

Zacks


IGI, Laboratories, Inc. (IG) was a big mover last session, as the company saw its shares surge nearly 12% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 40.1% in the past one-month time frame.

The company has seen 1 downward revision in the past month, while its Zacks Consensus Estimate moved lower over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

IGI, Laboratories, Inc. currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked players in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation.(CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






IGI LABORATORIES INC (IG): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)